$28M Chestnut Hill Hospital sale gets final approval

West Reading, Pa.-based Tower Health’s $28 million sale of Philadelphia-based Chestnut Hill Hospital to a consortium led by Philadelphia-based Temple University Health System has been approved by an Orphans Court judge, The Philadelphia Inquirer reported Dec. 2.

Advertisement

Temple will own 60 percent of the hospital, and its partners Meadowbrook, Pa.-based Redeemer Health and the Philadelphia College of Osteopathic Medicine will split the rest. The consortium could pay an additional $4 million to Tower Health for transition services. 

Under the terms of the agreement, the consortium will take over the 148-bed hospital on Jan. 1. 

“We believe there is significant opportunity to improve the quality of care” at Chestnut Hill, Temple’s CEO Mike Young told bond analysts on Nov. 17, which will lead to better community perception of “a hospital that’s been underperforming for decades.”

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.